NADAC acquisition cost data for POLYCIN EYE OINTMENT. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00574402135 | $2.64 | 2022-12-21 | Rx |
| 00574402135 | $2.64 | 2022-12-21 | Rx |
Generic: Bacitracin/Polymyxin B Sulfate | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $145.0K | 8,691 | 6,701 | $4.49 |
| 2020 | $6.5K | 388 | 323 | $4.62 |
| 2021 | $1.3K | 88 | 62 | $4.08 |
| 2022 | $910.89 | 60 | 43 | $3.77 |
| 2023 | $1.4K | 59 | 42 | $3.86 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| New York | $927.58 | 31 | 20 |
| New Jersey | $217.35 | 14 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.